NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 35 filers reported holding NYMOX PHARMACEUTICAL CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4 | -20.0% | 20,377 | +52.9% | 0.00% | -100.0% |
| Q1 2023 | $5 | -16.7% | 13,324 | -32.2% | 0.00% | 0.0% |
| Q4 2022 | $6 | -100.0% | 19,646 | +57.3% | 0.00% | -50.0% |
| Q1 2021 | $28,000 | -3.4% | 12,488 | +7.1% | 0.00% | -60.0% |
| Q3 2020 | $29,000 | -71.0% | 11,659 | -58.6% | 0.01% | -58.3% |
| Q2 2020 | $100,000 | +61.3% | 28,140 | -0.7% | 0.01% | +100.0% |
| Q4 2019 | $62,000 | – | 28,341 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Citizens Financial Corp | 35,100 | $89,000 | 0.08% |
| Geier Asset Management, Inc. | 35,000 | $91,000 | 0.07% |
| Patriot Financial Group Insurance Agency, LLC | 43,250 | $107,000 | 0.03% |
| Willow Creek Wealth Management Inc. | 24,224 | $60,000 | 0.02% |
| WEBSTER BANK, N. A. | 70,000 | $174,000 | 0.02% |
| Brown Advisory Securities, LLC | 28,000 | $69,000 | 0.01% |
| Cubic Asset Management, LLC | 11,250 | $28,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 25,613 | $64,000 | 0.00% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $62,000 | 0.00% |
| Sterling Investment Advisors, Ltd. | 2,500 | $6,000 | 0.00% |